1. Access to innovation through the national early access program and clinical trials for patients with malignant melanoma. Issue 13 (25th March 2021) Authors: Christen, Claire; Belgodère, Laetitia; Guillot, Bernard; Jumeau, Céline; Lorence, Annie; Kerouani‐Lafaye, Ghania; Brunel, Liora; Turcry, Florence; Monard, Adrien; Grudé, Francoise; Guyader, Gaëlle; Boudali, Lotfi; Albin, Nicolas Journal: Cancer Issue: Volume 127:Issue 13(2021) Page Start: 2262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years. (May 2021) Authors: Jacquet, Emmanuelle; Kerouani-Lafaye, Ghania; Grude, Francoise; Goncalves, Sergio; Lorence, Annie; Turcry, Florence; Brunel, Liora; Belgodere, Laetitia; Monard, Adrien; Guyader, Gaëlle; Boudali, Lotfi; Albin, Nicolas Journal: European journal of cancer Issue: Volume 149(2021) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Idelalisib-related pneumonitis. Issue 4 (25th February 2016) Authors: Haustraete, Eglantine; Obert, Julie; Diab, Samia; Abbes, Sarah; Zini, Jean-Marc; Valade, Sandrine; Lerolle, Nathalie; Albin, Nicolas; Arnulf, Bertrand; Bouaziz, Jean-David; Hussenet, Claire; Tazi, Abdellatif; Bergeron, Anne Journal: European respiratory journal Issue: Volume 47:Issue 4(2016) Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to the letter: Re: Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years. (October 2021) Authors: Jacquet, Emmanuelle; Monard, Adrien; Albin, Nicolas Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. Issue 8 (7th July 2022) Authors: Pham, Fiona Y.‐V.; Jacquet, Emmanuelle; Taleb, Amina; Monard, Adrien; Kerouani‐Lafaye, Ghania; Turcry, Florence; Brunel, Liora; Grudé, Françoise; Yoldjian, Isabelle; Sainte‐Marie, Isabelle; Boudali, Lotfi; Blay, Jean‐Yves; Albin, Nicolas Journal: International journal of cancer Issue: Volume 151:Issue 8(2022) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗